Company: TYRA
Filing Date: 2025-12-01
Form Type: 8-K
Source: 0001193125-25-303162
Chunk: 2

Company: Tyra Biosciences, Inc.
Filing Date: 2025-12-01
Form: 8-K
Item: Item 5.02
Chunk 2
---
 Employment Agreement, upon a termination without cause, due to death, due to disability, or resignation for good reason within 3 months prior to or 18 months after a change in control (such period, the “change in control period”), Mr. Ashar is entitled to (i) a cash lump sum payment equal to 18 months of his current annual base salary plus his then target annual bonus (ii) accelerated vesting of 100% of his unvested equity awards as of his date of termination, and (iii) payment or reimbursement of the COBRA premiums for him and his eligible dependents, or if coverage under COBRA is not available under the Company’s group health plan, the cash amount necessary to maintain his health coverage at the same coverage levels in effect as of the date of his termination, until the earliest of (a) 12 months from his date of termination, or (b) the date he becomes eligible for comparable health insurance coverage under a subsequent employer’s group health plan.

The foregoing description of the Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such agreement which will be filed by the Company as an exhibit to its Annual Report on Form10-Kfor the year ending December 31, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                       TYRA BIOSCIENCES, INC.   
  Date: December 1, 2025      By:      /s/ Alan Fuhrman         
                                       Alan Fuhrman